OptimizeRx Corporation
OPRX
$6.60
$0.172.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.02M | 779.00K | 1.53M | -2.20M | -78.00K |
| Total Depreciation and Amortization | 1.32M | 1.00M | 1.00M | 1.00M | 1.33M |
| Total Amortization of Deferred Charges | 81.00K | 254.00K | 510.00K | 265.00K | 55.00K |
| Total Other Non-Cash Items | 2.33M | 1.96M | 1.49M | 1.56M | 3.01M |
| Change in Net Operating Assets | -1.66M | -788.00K | 30.00K | 3.24M | -4.12M |
| Cash from Operations | 7.09M | 3.20M | 4.56M | 3.86M | 198.00K |
| Capital Expenditure | -11.00K | -10.00K | -10.00K | -27.00K | -17.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 217.00K | 0.00 | -34.00K | -57.00K | -103.00K |
| Cash from Investing | 206.00K | -10.00K | -44.00K | -84.00K | -120.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.50M | -500.00K | -4.50M | -500.00K | -2.50M |
| Issuance of Common Stock | 14.00K | 338.00K | -- | -- | -- |
| Repurchase of Common Stock | -962.00K | -96.00K | -5.00K | -87.00K | -324.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.45M | -258.00K | -4.51M | -587.00K | -2.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.85M | 2.93M | 12.00K | 3.19M | -2.75M |